Results 81 to 90 of about 103,351 (342)
Pediatric Neurology Briefs, 1990 A report of the Therapeutics and Technology Assessment Subcommittee of the American Academy of Neurology concludes that local injection of type A botulinum toxin (Botox) is proven as a safe and efficacious modality for the treatment of blepharospasm, cervical dystonia, and hemifacial spasm.
openaire +3 more sources
Validation of an Endoscopic Landmark for Injection of Internal Branch of Superior Laryngeal Nerve
The Laryngoscope, EarlyView.This study validates a transnasal endoscopic approach to target the internal branch of the superior laryngeal nerve (iSLN) via the piriform sinus. Cadaveric analysis showed this method enables precise localization with minimal variability, offering a promising technique for treating laryngeal sensory dysfunction.
Yuki Tanigami +4 more
wiley +1 more source
BOTOX injection to treat strabismus after infant botulism type B infection
American Journal of Ophthalmology Case Reports, 2020 Purpose: The significance of botulinum toxin to ophthalmologists is twofold. Botulism, a medical emergency, frequently presents with ocular findings including blurred vision, diplopia, ptosis, and photophobia as a result of the neurotoxin produced by ...
Sarah G. Bonaffini +2 more
doaj +1 more source
Cluster of Botulism among dutch tourists in Turkey, june 2008 [PDF]
, 2010 In June 2008, three Dutch tourists participating in a mini-cruise in Turkey needed urgent repatriation for antitoxin treatment because of symptoms of botulism.
Ouwerkerk, M., van +2 more
core +1 more source
Does the somatosensory temporal discrimination threshold change over time in focal dystonia? [PDF]
, 2017 BACKGROUND: The somatosensory temporal discrimination threshold (STDT) is defined as the shortest interval at which an individual recognizes two stimuli as asynchronous. Some evidence suggests that STDT depends on cortical inhibitory interneurons in the
Belvisi, Daniele +6 more
core +3 more sources
Barnes Hospital Bulletin [PDF]
, 1986 https://digitalcommons.wustl.edu/bjc_barnes_bulletin/1239/thumbnail ...
core +1 more source
Intratumoral Nerve Phased Development: A Promising Therapeutic Target
Medicine Bulletin, EarlyView.ABSTRACT The nervous system has emerged as a critical regulator of tumor biology, engaging in dynamic crosstalk with cancer cells. Although the protumorigenic role of innervation is well established, increasing attention is now directed toward reciprocal influences—how tumors actively shape and remodel local nerve networks within the tumor ...
Xiangxian Che +3 more
wiley +1 more source
Botulinum neurotoxin formulations: overcoming the confusion
Clinical, Cosmetic and Investigational Dermatology, 2018 Souphiyeh Samizadeh,1 Koenraad De Boulle2 1Great British Academy of Aesthetic Medicine, London, UK; 2Aalst Dermatology Clinic, Aalst, Belgium Abstract: Botulinum toxin A is produced by anaerobic spore-forming bacteria and is used for various therapeutic ...
Samizadeh S, De Boulle K
doaj
An integrated, cost-effective efficient chain to deliver botulinum toxin in optimal conditions.
International Journal of Integrated Care, 2019 Introduction: Botulinum toxin is increasingly used in clinical care for a variety of conditions that include facial spasms, bleharospasms, and other abnormal movement disorders.
Marian Gomez Beldarrain +4 more
doaj +1 more source
Botulinum toxin treatment of spasticity in diplegic cerebral palsy : a randomised, double-blind, placebo-controlled, dose-ranging study [PDF]
This study evaluated the efficacy and safety of three doses of botulinum toxin A (BTX-A; Dysport®) in 125 patients (mean age 5.2 years, SD 2; 54% male)with dynamic equinus spasticity during walking. Participants were randomized to receive Dysport (10,
Bakheit +32 more
core +1 more source